Last Update Time:
19-Mar-2025 16:00:00
ISIN:
INE179A01014
Sector:
Fast Moving Consumer Goods
Symbol:
PGHH
Procter & Gamble Hygiene and Health Care Limited
₹13,451.00
₹-48.05
(-0.36%)
▼
Prev. Close
₹13,499.05
Open
₹13,600.00
Close
₹13,511.75
Range
₹12,778.45 - ₹14,123.55
High
₹13,617.90
Low
₹13,450.00
Ind. Close
₹0.00
VWAP
₹13,509.12
The current stock price of Procter & Gamble Hygiene and Health Care Limited is ₹13,451.00, with a target price range between ₹12,778.45 and ₹14,123.55. The stock has experienced a price change of ₹-48.05 (-0.36%), reflecting recent market volatility.
Today's opening price was ₹13,600.00, while the previous close stood at ₹13,499.05.
The market trend suggests a potential downtrend, with investors exercising caution due to recent declines. Analysts recommend closely monitoring support levels.
For real-time stock market updates, live share prices, and stock analysis, stay tuned. Understanding key stock metrics like VWAP, high-low range, and market momentum can help traders make informed investment decisions.
Procter & Gamble Hygiene and Health Care Limited Price Chart
Procter & Gamble Hygiene and Health Care Limited Pre Open Market Overview: 19-Mar-2025
Key Metrics:
- IEP (Indicative Equilibrium Price): 13600
- Previous Close Price: 13499.05
- Change: 100.95%
- Total Traded Volume: 18
- Total Buy Quantity: 455
- Total Sell Quantity: 227
| Price | Buy Qty | Sell Qty |
|---|---|---|
| 13,490.00 | 4.00 | 0.00 |
| 13,499.05 | 1.00 | 0.00 |
| 13,500.00 | 5.00 | 0.00 |
| 13,510.00 | 33.00 | 0.00 |
| 13,511.00 | 5.00 | 0.00 |
| 13,600.00 | 0.00 | 5.00 |
| 13,620.00 | 0.00 | 1.00 |
| 13,640.00 | 0.00 | 5.00 |
| 13,641.00 | 0.00 | 1.00 |
| 13,650.00 | 0.00 | 1.00 |
ATO Data:
- Buy Quantity (ATO): 0
- Sell Quantity (ATO): 0
Order Book
| Bid | Qty | Ask | Qty |
|---|---|---|---|
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
Total Buy Quantity: 455
Total Sell Quantity: 227
Shareholding Patterns of Procter & Gamble Hygiene and Health Care Limited
Key Trade Statistics of Procter & Gamble Hygiene and Health Care Limited
| Trade Information | Details |
|---|---|
| Traded Volume (Lakhs) | 0.05 |
| Traded Value (₹ Cr.) | 6.84 |
| Total Market Cap (₹ Cr.) | 43,662.94 |
| Free Float Market Cap (₹ Cr.) | 12,701.24 |
| Impact cost | 0.07 |
| Quantity Traded | 5,060.00 |
| Deliverable Quantity | 3,747.00 |
| % of Quantity to Traded | 74.05 |
| Security VaR | 7.19 |
| Index VaR | N/A |
| VaR Margin | 9 |
| Extreme Loss Rate | 3.5 |
| Adhoc Margin | N/A |
| Applicable Margin Rate | 12.5 |
| Face Value | 10 |
Key Price Statistics of Procter & Gamble Hygiene and Health Care Limited
The 52-week high for Procter & Gamble Hygiene and Health Care Limited was ₹17,745.00, recorded on 26-Jul-2024. On the other hand, the 52-week low stands at ₹13,150.00, with the lowest value recorded on 11-Mar-2025.
The upper band for trading is ₹16,198.85, and the lower band is ₹10,799.25. The price band is 20%.
The stock's daily volatility stands at 1.16, while the annualized volatility is 22.16. The tick size for trading is ₹0.05.
| Price Information | Details |
|---|---|
| 52 Week High (26-Jul-2024) | 17,745.00 |
| 52 Week Low (11-Mar-2025) | 13,150.00 |
| Upper Band | 16,198.85 |
| Lower Band | 10,799.25 |
| Price Band (%) | 20 |
| Daily Volatility | 1.16 |
| Annualised Volatility | 22.16 |
| Tick Size | 0.05 |
Key Securities Statistics of Procter & Gamble Hygiene and Health Care Limited
| Securities Information | Details |
|---|---|
| Status | Listed |
| Trading Status | Active |
| Date of Listing | 07-Jul-2004 |
| Adjusted P/E | 61.21 |
| Symbol P/E | 61.21 |
| Index | NIFTY FMCG |
| Macro-Economic Sector | Fast Moving Consumer Goods |
| Sector | Fast Moving Consumer Goods |
| Industry | Personal Products |
| Basic Industry | Personal Care |
Security Status of Procter & Gamble Hygiene and Health Care Limited
| Title | Details |
|---|---|
| Board Status | Main |
| Trading Segment | Normal Market |
| Session No. | - |
| Class of Shares | Equity |
| SDD Compliance | - |
| Name of Compliance Officer | - |
Announcements of Procter & Gamble Hygiene and Health Care Limited
| Subject | Date |
|---|---|
| Integrated Filing- Financial | 18-Feb-2025 |
| Outcome of Board Meeting-XBRL | 12-Feb-2025 |
| Updates | 11-Feb-2025 |
| Record Date | 11-Feb-2025 |
| Dividend | 11-Feb-2025 |
| Financial Result Updates | 11-Feb-2025 |
| Press Release | 11-Feb-2025 |
| Dividend | 11-Feb-2025 |
Corporate Actions of Procter & Gamble Hygiene and Health Care Limited
| Face Value | Purpose | Ex-Date |
|---|---|---|
| 10 | Interim Dividend - Rs 110 Per Share | 20-Feb-2025 |
| 10 | Annual General Meeting/Dividend - Rs 95 Per Share | 19-Nov-2024 |
| 10 | Interim Dividend - Rs 100 Per Share/ Special Dividend - Rs 60 Per Share | 09-Feb-2024 |
| 10 | Annual General Meeting/Dividend - Rs 105 Per Share | 17-Nov-2023 |
| 10 | Interim Dividend - Rs 80 Per Share | 08-Feb-2023 |
| 10 | Annual General Meeting/Dividend - Rs 65 Per Share | 04-Nov-2022 |
| 10 | Interim Dividend - Rs 95 Per Share | 08-Feb-2022 |
| 10 | Annual General Meeting/Dividend - Rs 80 Per Share | 09-Nov-2021 |
| 10 | Special Dividend - Rs 150 Per Share | 11-May-2021 |
| 10 | Interim Dividend - Rs 85 Per Share | 10-Feb-2021 |
| 10 | Annual General Meeting/Dividend - Rs 105 Per Share | 13-Nov-2020 |
| 10 | Dividend Rs 48 Per Eq Sh | 19-Nov-2019 |
| 10 | Interim Dividend - Rs 40 Per Share | 15-Feb-2019 |
| 10 | Annual General Meeting/Dividend Rs 40 Per Share | 20-Nov-2018 |
| 10 | Dividend - Rs 27/- Per Share | 07-Nov-2017 |
| 10 | Special Interim Dividend Rs 362/- Per Share | 17-May-2017 |
| 10 | Dividend Rs 36/- Per Share | 24-Nov-2016 |
| 10 | Dividend - Rs 30.25/- Per Share | 19-Oct-2015 |
| 10 | Annual General Meeting / Dividend - Rs 27.50/- Per Share | 08-Sep-2014 |
| 10 | Annual General Meeting/Dividend Rs 25/- Per Share | 21-Nov-2013 |
Board Meetings of Procter & Gamble Hygiene and Health Care Limited
Financial Results of Procter & Gamble Hygiene and Health Care Limited
Company Directory of Procter & Gamble Hygiene and Health Care Limited
| Web Address | Office | Address | City |
|---|---|---|---|
| www.pg.com/en_IN | Registered Office | Plot No.495, P&G Plaza, Cardinal Gracias Road,Chakala Andheri (East) | MUMBAI |
| www.pg.com/en_IN | Transfer Agent | Link Intime India Private Ltd C-13, Pannalal Silk Mills Compound, L.B.S. Marg, Bhandup (West), | MUMBAI |
Insider Trading of Procter & Gamble Hygiene and Health Care Limited
| Reg. Clause | Acq./Disp. | Sec. Value | Txn Type |
|---|---|---|---|
| 7(2) | Procter & Gamble Overseas India BV | 7634369192 | Buy |
| 7(2) | Rosemount LLC | 7634369192 | Sell |
| 7(2) | Procter & Gamble Overseas India BV | 0 | Buy |
| 7(2) | Procter & Gamble Asia Holding BV | 0 | Sell |
Annual Reports of Procter & Gamble Hygiene and Health Care Limited
Investor Complaints of Procter & Gamble Hygiene and Health Care Limited
Event Calendar of Procter & Gamble Hygiene and Health Care Limited
| Purpose | Details |
|---|---|
| Results/Dividend | To consider and approve the audited financial accounts for the year ended June 30, 2010 and unaudited financial results for the quarter ended June 30, 2010. The Board will also consider recommending dividend, if any, for the financial year ended June 30, 2010. |
| Results/Dividend | To consider and approve the audited financial results for the year ended June 30, 2011 and unaudited financial results for the quarter ended June 30, 2011. Further, the Board will also consider recommending dividend, if any, for the financial year ended June 30, 2011. |
| Results/Dividend | The Company had informed the Exchange that the meeting of the Board of Directors of the company is scheduled to be held on August 23, 2012 to consider and approve the Audited financial results for the year ended June 30, 2012. The Company has now informed the Exchange that the Board will consider recommending dividend (if any) at the Meeting of the Board of Directors Convened on August 23, 2012. |
| Results | To consider and approve the Unaudited Financial Results for the quarter ended December 31, 2012. |
| Results | To consider and approve the Unaudited Financial Results for the quarter ended December 31, 2012 |
| Results | To consider and approve the Unaudited Financial Results for the quarter and nine months ended March 31, 2013. |
| Results/Dividend | To consider and approve Audited Financial Results and Statements for the Financial Year ended June 30, 2013 and to consider recommendation of dividend (if any). |
| Results | To consider and approve the Unaudited Financial Results for the Quarter ended September 30, 2013 |
| Results | To consider and approve the Unaudited Financial Results for the Quarter ended September 30, 2013. |
| Results | To consider and approve the Unaudited Financial Results for the quarter ended December 31, 2013. |
| Results | To consider and approve the Unaudited Financial Results for the quarter and nine months ended March 31, 2014. |
| Board meeting Rescheduled | The Company had informed the Exchange regarding a Board Meeting to be held on April 29, 2014 to consider and approve the Unaudited Financial Results for the quarter and nine months ended March 31, 2014. The Company has now informed that the said meeting of the Board of Directors of the Company has been re-scheduled to be held on May 7, 2014 to consider and approve the Unaudited Financial Results for the quarter and nine months ended March 31, 2014. |
| Board meeting Rescheduled | The Company had informed the Exchange that the meeting of the Board of Directors of the Company is scheduled to be held on April 29, 2014, to consider and approve the Unaudited Financial Results for the quarter and nine months ended March 31, 2014.. The Company has now informed the Exchange that the aforesaid meeting has been resecheduled on May 07, 2014, to consider and approve the Unaudited Financial Results for the quarter and nine months ended March 31, 2014. |
| Results | inter alia, to consider and approve Audited financial Result and Statements for the Financial Year ended June 30, 2014. |
| Results/Dividend | The Company had informed the Exchange that the meeting of the Board of Directors of the Company is scheduled to be held on August 12, 2014, inter alia, to consider and approve Audited Financial results and Statement for the Financial Year ended June 30, 2014. The Company has now informed the Exchange that in the aforesaid board meeting, the Board of Directors shall also consider recommendation of dividend (if any). (Purpose Revised) |
| Results | inter alia, to consider and approve Unaudited Financial Results for the Quarter ended September 30, 2014. |
| Results | Inter alia, to consider and approve Unaudited Financial Results for the quarter and six months ended December 31, 2014. |
| Results | We would like to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Friday, May 8, 2015, inter alia, to consider and approve Unaudited Financial Results for the quarter and nine months ended March 31, 2015. |
| Board meeting Rescheduled | PGHH : 28-Aug-2015 : The Company had informed the Exchange regarding the meeting of the Board of Directors of the Company scheduled to be held on August 29, 2015 inter alia consider and approve Audited Financial Results and Statements for the Financial year ended June 30, 2015 and to consider recommendation of dividend (if any). The Company has now informed the Exchange that the aforesaid Board Meeting has been rescheduled to be held on August 28, 2015 due to non-availability of Directors. |
| Results/Dividend | inter alia, to consider and approve Audited Financial Results and Statements for the Financial Year ended June 30, 2015 and to consider recommendation of dividend (if any) |
| Results | Inter alia, to consider and approve Unaudited Financial Results for the quarter ended September 30, 2015. |
| Results | inter alia, to consider and approve Unaudited Financial Results for the Quarter ended September 30, 2015. |
| Results | inter alia, to consider and approve Unaudited Financial Results for the quarter and six months ended December 31, 2015. |
| Results | Inter alia, to consider and approve Unaudited Financial Results for the quarter and nine months ended March 31, 2016. |
| Results/Dividend | inter alia, to consider and approve Audited Financial Results and Statements for the Financial Year ended June 30, 2016 and to consider recommendation of dividend (if any). |
| Results | Inter alia, to consider and approve Unaudited Financial Results for the quarter ended September 30, 2016. |
| Results | inter alia, to consider and approve Unaudited Financial Results for the quarter ended December 31, 2016. |
| Results/Dividend | Inter alia, to consider and approve Unaudited Financial Results for the quarter and nine months ended March 31, 2017 and to consider declaration of interim dividend (if any). |
| Results/Dividend | inter alia, to consider and approve Audited Financial Results and Statements for the Financial Year ended June 30, 2017 and to consider recommendation of dividend (if any). |
| Results | inter alia, to consider and approve Unaudited Financial Results for the quarter ended September 30, 2017. |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2018 |
| Financial Results/Dividend | To consider and approve the financial results for the period ended Jun 30, 2018 and recommend final dividend (if any) |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2018 |
| Financial Results/Dividend | We refer to our letter dated January 11, 2019 informing that a meeting of the Board of Directors of the Company is scheduled to be held on Thursday, February 7, 2019 to consider and approve Unaudited Financial Results for the quarter ended December 31, 2018. We would like to further inform you that at the said meeting the Board would also consider declaration of interim dividend (if any).Kindly take the same on record. |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2018 |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2019 |
| Financial Results/Dividend | We would like to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, August 21, 2019, inter alia, to consider and approve Audited Financial Results and Statements for the Financial Year ended June 30, 2019 and to consider recommendation of dividend (if any). |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2019 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2019 |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2020 |
| Financial Results/Dividend | To consider and approve Audited Financial Results and Statements for the Financial Year ended June 30, 2020 and to consider recommendation of dividend (if any). |
| Financial Results | To consider and approve the Unaudited financial results for the period ended September 30, 2020 |
| Financial Results/Dividend | We refer to our letter dated January 11, 2021 informing that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, February 3, 2021 to consider and approve Unaudited Financial Results for the quarter ended December 31, 2020. We would like to further inform you that at the said meeting the Board would also consider declaration of interim dividend (if any).Kindly take the same on record. |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2020 |
| Financial Results/Dividend | To consider and approve the Unaudited financial results for the period ended March 31, 2021 and consider declaration of dividend, if any. |
| Financial Results/Dividend | We would like to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, August 25, 2021, inter alia, to consider and approve Audited Financial Results and Statements for the Financial Year ended June 30, 2021 and to consider recommendation of dividend (if any). |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2021 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2021 |
| Financial Results/Dividend | Update on Board Meeting scheduled to be held on February 1, 2022 |
| Financial results | Procter & Gamble Hygiene and Health Care Limited has informed the Exchange about Board Meeting to be held on 28-Apr-2022 to consider financial statements for the period ended March 2022 |
| Financial results | We would like to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, November 2, 2022, inter alia, to consider and approve unaudited Financial Results for the quarter ended September 30, 2022. Kindly take the same on record. |
| Financial Results/Dividend | To consider and approve the financial results for the period ended December 31, 2022 and dividend |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2023 |
| Financial Results/Dividend | We would like to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Monday, August 28, 2023, inter alia, to consider and approve Audited Financial Results and Statements for the Financial Year ended June 30, 2023 and to consider recommendation of dividend (if any).Kindly take the same on record. |
| Financial Results | To consider and approve the unaudited financial results for the period ended September 30, 2023 |
| Financial Results/Dividend | To consider and approve the financial results for the period ended December 31, 2023 and to consider declaration of interim dividend for the financial year 2023-24, if any. |
| Financial Results | We would like to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, April 30,2024, inter alia, to consider and approve Unaudited Financial Results for the Quarter ended March 31, 2024. |
| Financial Results/Dividend | To consider and approve the financial results for the financial year ended June 30, 2024 and to consider recommendation of dividend , if any. |
| Financial Results/Dividend | PGHH : 28-Aug-2024 : The Company has informed the Exchange that a Board meeting to be held on August 29, 2024 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on August 28, 2024, To consider and approve the financial results for the period ended Jun 30, 2024 and dividend |
| Financial Results | To consider and approve the unaudited financial results for the period ended September 30, 2024 |
| Financial Results | To consider and approve the unaudited financial results for the period ended December 31, 2024 |
| Financial Results/Dividend | To consider and approve the financial results for the period ended December 31, 2024 and dividend |
Share Transfers of Procter & Gamble Hygiene and Health Care Limited
Voting Results of Procter & Gamble Hygiene and Health Care Limited
| Date of Mtg. | Mtg. Type | Resolution |
|---|---|---|
| 26-NOV-2024 | AGM | To receive, consider and adopt the Audited Balance Sheet as at June 30, 2024 and the Statement of Profit and Loss for the Financial Year endednon that date, together with the Reports of the Auditors and Directors thereon. |
| 26-NOV-2024 | AGM | Ratification of remuneration payable to the Cost Auditor for the Financial Year 2024-25 |
| 26-NOV-2024 | AGM | To appoint a Director in place of Mr. Gagan Sawhney, Non-Executive Director (DIN 08279568), who retires by rotation and being eligible, offers himself for re-appointment. |
| 26-NOV-2024 | AGM | To appoint a Director in place of Mr. Ghanashyam Hegde, Executive Director (DIN 08054712), who retires by rotation and being eligible, offers himself for re-appointment. |
| 26-NOV-2024 | AGM | To confirm payment of interim dividend and to declare final dividend for the Financial Year ended June 30, 2024. |
| 03-JUL-2024 | Postal Ballot | 1 - Appointment of Kumar Venkatasubramanian (DIN 08144200) as a Director and Managing Director of the Company for a period of five years, effective May 1, 2024 |
| 13-MAR-2024 | Postal Ballot | Appointment of Dr. Ashima Goyal (DIN 233635) as Non- Executive Independent Director of the Company effective March 19,2024, for a period of five years. |
| 24-NOV-2023 | AGM | To receive, consider and adopt the Audited Balance Sheet as at June 30, 2023 and the Statement of Profit and Loss for the Financial Year ended on that date, together with the Reports of the Auditors and Directors thereon. |
| 24-NOV-2023 | AGM | Approval of material related party transaction under Regulation 23 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 |
| 24-NOV-2023 | AGM | Payment of Commission to the Non-Executive Directors of the Company |
| 24-NOV-2023 | AGM | Ratification of remuneration payable to the Cost Auditor for the Financial Year 2023-24 |
| 24-NOV-2023 | AGM | To appoint a Director in place of Mr. Pramod Agarwal, Non-Executive Director (DIN 00066989), who retires by rotation and being eligible, offers himself for re-appointment. |
| 24-NOV-2023 | AGM | To appoint a Director in place of Mr. Karthik Natarajan, Non-Executive Director (DIN 06685891), who retires by rotation and being eligible, offers himself for re-appointment. |
| 24-NOV-2023 | AGM | To confirm payment of interim dividend and to declare final dividend for the Financial Year ended June 30, 2023. |
| 15-NOV-2022 | AGM | To receive, consider and adopt the Audited Balance Sheet as at June 30, 2022 and the Statement of Profit and Loss for the Financial Year ended on that date, together with the Reports of the Auditors and Directors thereon. |
| 15-NOV-2022 | AGM | To appoint Mr. Gurcharan Das as an Independent Director of the Company effective September 1, 2022 |
| 15-NOV-2022 | AGM | To re-appoint M/s. Kalyaniwalla & Mistry LLP, Chartered Accountants (Firm Reg. No.104607W/W-100166) as Auditors of the Company to hold office from the conclusion of this Meeting until the conclusion of the Sixty-Third Annual General Meeting, on such remuneration and reimbursement of out-of-pocket expenses, as the Board of Directors may decide |
| 15-NOV-2022 | AGM | To appoint a Director in place of Ms. Sonali Dhawan (DIN 06808527), who retires by rotation and being eligible, offers herself for re-appointment |
| 15-NOV-2022 | AGM | To appoint a Director in place of Mr. Gagan Sawhney (DIN 08279568), who retires by rotation and being eligible, offers himself for re-appointment. |
| 15-NOV-2022 | AGM | To confirm payment of interim dividend and to declare final dividend for the Financial Year ended June 30, 2022 |
FAQs on Procter & Gamble Hygiene and Health Care Limited
Disclaimer: The information provided here is for informational purposes only and should not be considered financial advice. Please do your own research and consult with a financial professional before making any investment decisions.